A study led by researchers at the Icahn School of Medicine at Mount Sinai has identified a potential drug that is able to drive human insulin-producing beta cells to multiply. This may prove to be a potential treatment for diabetes, a disease characterized by a lack of beta cells in the pancreas to produce insulin, the hormone needed to regulate blood glucose levels. The findings are published in the online journal

Researchers from Saint Louis University Medical Center have discovered a way to prevent type 1 diabetes from a mice model of the disease. The new approach developed by the scientists stops the destruction of beta cells and preserves the production of insulin. Findings of the said study were published in the journal Endocrinology. Type 1 diabetes is a chronic disease characterized by destruction of the pancreatic be

People suffering from diabetes do not have enough insulin in their body essential for regulating their blood sugar levels. A primary cause of this is that diabetics do not have enough pancreatic beta cells to produce enough insulin in their body. This lack of insulin making cells may someday be addressed as researchers have discovered a mechanism in the body that may convert other cell types into pancreatic beta ce